Two-weekly or Three-weekly CHOP Chemotherapy for the Treatment of Aggressive Non-Hodgkin's Lymphomas
Osama Ahmed Abbas;
Abstract
The aim of this work is to evaluate the safety & the superior efficacy of compressed-cycle (14-days) standard-dose CHOP supported with recombinant granulocyte colony-stimulating factor in comparison with the standard CHOP given every 3 weeks.
This study
This study
Other data
| Title | Two-weekly or Three-weekly CHOP Chemotherapy for the Treatment of Aggressive Non-Hodgkin's Lymphomas | Authors | Osama Ahmed Abbas | Keywords | Two-weekly or Three-weekly CHOP Chemotherapy for the Treatment of Aggressive Non-Hodgkin's Lymphomas | Issue Date | 2007 | Description | The aim of this work is to evaluate the safety & the superior efficacy of compressed-cycle (14-days) standard-dose CHOP supported with recombinant granulocyte colony-stimulating factor in comparison with the standard CHOP given every 3 weeks. This study |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.